Company Data
Pharvaris N.V.
Ticker
PHVS
Current Price
$30.16 1%
Market Cap
$2.1B
Price Target
Refer to Report
Volume
413.9K
52wk Range
$15.46 - $33.33
Overview
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.